Goto, Hideaki
Shimono, Yohei http://orcid.org/0000-0002-6256-4704
Funakoshi, Yohei
Imamura, Yoshinori
Toyoda, Masanori
Kiyota, Naomi
Kono, Seishi
Takao, Shintaro
Mukohara, Toru
Minami, Hironobu
Article History
Received: 29 January 2018
Revised: 28 July 2018
Accepted: 2 August 2018
First Online: 3 September 2018
Compliance with ethical standards
:
: YS, HG and HM are listed as co-inventors on a Japanese patent application that describes the use of adipsin as therapeutic targeting of cancer and CSCs (2018-027603). The remaining authors declare that they have no conflict of interest.
: Primary human breast cancer specimens were obtained from the consented patients who were admitted to Kobe University Hospital. All participants provided written informed consent for this investigation. The investigation was approved by the Institutional Review Board at Kobe University (permission number: 1299). All animal experiments were performed under the approval of the Kobe University Animal Care and Use Committee (permission number: P150802)